Mitigating for Impacts on Trial Endpoints

At CTAD 2023, our Clinical Assessment Technologies team presented their poster, “A Meta-Analysis to Demonstrate the Incidence of Placebo Effect in Alzheimer’s Disease and Mild Cognitive Impairment Trials: Mitigating for Impacts on Trial Endpoints.” Check out the full poster to see their conclusions about the presence of placebo response in efficacy trials and their solutions for how to minimize the impact of the response on trial endpoints.

Meet the author